R1	Has_negation Arg1:T6 Arg2:T7	
R2	Has_value Arg1:T8 Arg2:T9	
R3	Subsumes Arg1:T6 Arg2:T8	
R4	Has_qualifier Arg1:T5 Arg2:T4	
R5	Has_qualifier Arg1:T5 Arg2:T3	
R6	Has_qualifier Arg1:T5 Arg2:T2	
R7	AND Arg1:T5 Arg2:T6	
R8	Has_value Arg1:T12 Arg2:T13	
R10	Has_value Arg1:T14 Arg2:T15	
R9	AND Arg1:T11 Arg2:T12	
R11	AND Arg1:T12 Arg2:T16	
R12	Has_negation Arg1:T18 Arg2:T19	
R13	AND Arg1:T21 Arg2:T20	
R14	Has_value Arg1:T22 Arg2:T23	
R15	Has_value Arg1:T24 Arg2:T25	
R16	Has_qualifier Arg1:T31 Arg2:T32	
*	OR T29 T34 T31
*	OR T35 T36
R17	Has_index Arg1:T37 Arg2:T38	
R18	Has_temporal Arg1:T35 Arg2:T37	
R19	Subsumes Arg1:T42 Arg2:T43	
R20	Has_index Arg1:T45 Arg2:T44	
*	OR T40 T41 T42
R21	Has_temporal Arg1:T40 Arg2:T45	
R22	Has_qualifier Arg1:T40 Arg2:T47	
R23	AND Arg1:T11 Arg2:T14	
R24	AND Arg1:T14 Arg2:T16	
R25	Has_value Arg1:T24 Arg2:T26	
*	OR T30 T34 T31
T1	Non-query-able 0 48	The patients signed the written informed consent
T2	Qualifier 76 84	operable
T3	Qualifier 85 95	unilateral
T4	Qualifier 96 104	invasive
T5	Condition 105 119	breast cancers
T6	Condition 128 146	distant metastasis
T7	Negation 120 127	without
T8	Measurement 147 152	stage
T9	Value 153 167	I, II, and III
T11	Condition 174 186	breast tumor
T12	Measurement 189 208	positive ER/PR rate
T13	Value 212 215	<1%
T14	Measurement 221 243	positive ER-beta1 rate
T15	Value 247 251	=10%
T16	Procedure 255 258	IHC
T18	Procedure 293 320	neoadjuvant hormone therapy
T19	Negation 279 289	no history
T21	Condition 341 365	normal cardiac functions
T20	Procedure 369 385	echocardiography
T22	Measurement 402 413	ECOG scores
T23	Value 418 422	=0-2
T24	Person 425 431	Female
T25	Value 447 454	= 18yrs
T26	Value 460 467	= 65yrs
T28	Pregnancy_considerations 470 563	The patients are non-pregnant, and disposed to practice contraception during the whole trial.
T29	Procedure 588 612	neoadjuvant chemotherapy
T30	Procedure 618 625	surgery
T31	Procedure 647 665	radical mastectomy
T32	Qualifier 629 646	directly modified
T34	Procedure 669 694	breast-conserving surgery
T35	Procedure 701 727	sentinel lymph node biopsy
T36	Procedure 731 761	axillary lymph node dissection
T37	Temporal 763 795	after diagnosis of breast cancer
T38	Reference_point 769 795	diagnosis of breast cancer
T40	Procedure 821 833	chemotherapy
T41	Procedure 835 852	radiation therapy
T42	Procedure 856 872	targeted therapy
T43	Drug 873 882	herceptin
T44	Reference_point 890 897	surgery
T45	Temporal 884 897	after surgery
T46	Procedure 890 897	surgery
T47	Qualifier 915 934	2013 NCCN guideline
T49	Non-query-able 937 989	The results of patients' blood tests are as follows:
